MG
QTTB icon

Michael Gelband’s Q32 Bio QTTB Stock Holding History

Michael Gelband’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
+11,336
New +$94.7K ﹤0.01% 1448
2022
Q1 		– Sell
-993
Closed -$65K – 2748
2021
Q4 		$65K Sell
993
-381
-28% -$37K ﹤0.01% 2008
2021
Q3 		$195K Buy
1,374
+366
+36% +$46.6K ﹤0.01% 1791
2021
Q2 		$132K Buy
+1,008
New +$126K ﹤0.01% 2090
2020
Q4 		– Sell
-1,563
Closed -$301K – 2451
2020
Q3 		$301K Buy
+1,563
New +$350K 0.01% 1284

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Michael Gelband's QTTB Position: Q2 2026 in Review

Michael Gelband opened a new position in Q32 Bio (QTTB) in Q2 2026: 11,336 shares worth $144K. The stake represents ﹤0.01% of the portfolio and ranks #1448 among its holdings. This is a return to the name: Michael Gelband previously reported a position in QTTB as recently as Q4 2021.

Michael Gelband first reported a position in QTTB in Q3 2020 and has held it in 5 quarters since. The position peaked at $301K in Q3 2020. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Michael Gelband held 11,336 shares of Q32 Bio worth $144K as of Q2 2026.
  • Q32 Bio was a new Michael Gelband position in Q2 2026.
  • Q32 Bio made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1448 holding.
  • Michael Gelband first reported a position in Q32 Bio in Q3 2020 and has held it in 5 quarters since.
  • Michael Gelband's Q32 Bio position peaked at $301K in Q3 2020.
  • 72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.